ABC1 - D.A. Cameron - Managing costs in higher-income countries
•
0 recomendaciones•359 vistas
Recomendados
Recomendados
Más contenido relacionado
La actualidad más candente
La actualidad más candente (8)
Similar a ABC1 - D.A. Cameron - Managing costs in higher-income countries
Similar a ABC1 - D.A. Cameron - Managing costs in higher-income countries (20)
Más de European School of Oncology
Más de European School of Oncology (20)
Último
Último (20)
ABC1 - D.A. Cameron - Managing costs in higher-income countries
- 1. Managing costs in higher-income countries David Cameron University of Edinburgh
- 2. Economics
- 3. Is there anything more to be said?
- 4. France Highest per capita health care expenditure in Europe including €14 billion each year on cancer. Estimated annual GDP loss of €17 billion from cancer. ~ 20% of all cancer spend is on drugs
- 10. Productivity is falling… Even allowing for inflation, industry is investing twice as much in R&D as it was a decade ago to produce two-fifths of the new medicines…..
- 12. New models ? Phase I. Many drugs………………………… Phase II. Fewer drugs…………… Phase III. Few drugs Phase I. € Phase II. €€ Phase III. €€€€€€€€€€€€€€€ Market €€€€€€€€€€€€€€€€€€€€€€€€€€€€€€€€€ Phase I/II. Some drugs… Phase II/III smaller, less data Phase I/II. € Phase II/III. €€€€ Market €€€€€€€€€€€€€
- 14. Choice in spending for society
- 20. Make drug development AND drug use cost-effective
Notas del editor
- This slide has presented many times before, showing that whilst R&D spending has continued to increase, the number of new medicines approved has declined, so productivity of pharma R&D is falling.